Editas Medicine, Inc. $300,000,000 COMMON STOCK SALES AGREEMENTStock Sales Agreement • May 14th, 2021 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
Editas Medicine, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
